夏去秋来，携着充沛的热情，2024年全球制药行业的焦点将再次聚集在意大利的时尚与设计之都——米兰，备受瞩目的CPHI米兰展（CPHI Milan 2024）将于10月8日至10日在米兰国际展览中心（Fiera Milano）隆重举行。作为全球最大的制药行业专业展览会之一，CPHI米兰展不仅是一个展示最新产品和技术的平台，更是一个促进全球制药行业交流与合作的重要场所。
As summer transitions into autumn, the global pharmaceutical industry is set to gather once again in Milan, the vibrant capital of fashion and design, for the highly anticipated CPHI Milan Show 2024. From October 8th to 10th, the Milan International Exhibition Center (Fiera Milano) will host one of the world’s largest and most renowned pharmaceutical events. This premier exhibition will not only showcase the latest products and technologies but will also serve as a key platform for industry professionals to connect, collaborate, and exchange ideas.
10.8-102024米兰CPHI制药展
本届展会以“在制药行业的核心”为主题，庆祝CPHI系列展会团结制药行业35周年，预计将吸引来自全球166多个国家的62,000名参与者和2,400家参展公司，其中包括150多位顶尖的国际专家演讲者，他们将在100多场内容会议中分享他们的见解和经验。
This year’s show, themed “At the Heart of Pharma,” marks the 35th anniversary of the CPHI series. It will welcome over 62,000 participants and 2,400 exhibitors from more than 166 countries, along with over 150 leading international experts who will share their knowledge through 100 insightful conference sessions.
富祥药业展位信息
富祥药业诚挚邀请您参加2024米兰CPHI制药展。CPHI米兰展，不仅是产品与技术的展示平台，更是全球制药人交流思想、共享资源的宝贵契机。让我们在这个充满机遇与挑战的舞台上，共同见证制药行业的每一次飞跃，携手开创更加美好的明天。期待在金秋十月，与您共赴米兰之约，共襄盛举，共同见证制药行业的创新与发展。富祥药业在4B110展位欢迎您的光临！
Fushine Pharmaceutical warmly invites you to attend the 2024 CPHI Milan Exhibition. This event is not just a showcase of products and technologies but a unique opportunity for global pharmaceutical professionals to network and share resources. Join us as we explore the challenges and opportunities of the pharmaceutical industry and work together to create a brighter future. We look forward to meeting you this autumn in Milan and welcoming you to booth 4B110!
关于富祥药业
作为全球重要的舒巴坦、他唑巴坦系列产品的主要供应商，国内为数不多的从起始原料到下游原料药全产业链布局的碳青霉烯培南类产品的主要生产商、全球洛韦类药物中间体主要的供应商，富祥药业以“精心制药、呵护健康”为己任，多年来深耕医药产业，聚焦抗病毒类、抗细菌类药物，在国内外客户中享有良好的声誉并实现共赢合作，产品销往全球数十个国家和地区，是国家高新技术企业、国家知识产权优势企业、江西省制造业单项冠军企业、江西省优秀企业、江西省创新型试点企业，并持续多年入选中国化药企业TOP100！
As a leading global supplier of sulbactam and tazobactam products, a major manufacturer of carbapenem antibiotics from raw materials to finished APIs, and a top provider of key intermediates for antiviral drugs, Fushine Pharmaceutical takes pride in its commitment to healthcare. With a strong focus on antiviral and antibacterial therapies, we have earned a solid reputation among customers worldwide, fostering successful partnerships and expanding our reach to numerous countries and regions. We are proud to be recognized as a National High-Tech Enterprise, a National Intellectual Property Advantage Enterprise, a Manufacturing Champion of Jiangxi Province, and one of the Top 100 Chemical Pharmaceutical Ente and one of the Top 100 Chemical Pharmaceutical Ente and one of the Top 100 Chemical Pharmaceutical Enterprises in China.
依托多年来医药行业经验累积形成的质量管理与EHS管理能力、扎实的工艺开发和高标准规模化的生产制造能力，大力发展锂电池电解液添加剂业务和合成生物学微生物蛋白业务，致力于成为全球知名的制药企业、全球新能源材料主要供应商、全球领先的微生物蛋白生产企业。
Leveraging our decades of expertise in quality management, EHS standards, and large-scale production, we are also expanding into new industries, such as lithium battery electrolyte additives and synthetic biology-based mycoprotein. Our goal is to become a globally recognized pharmaceutical company, a leading supplier of new energy materials, and a pioneer in mycoprotein production.
本文作者可以追加内容哦 !
